Michael Nugent, Prof Carolyn Sue, Prof Robyn Ward, Irina White and Deb Willcox
New strategic framework for the Kolling It has been an important time for the Kolling following the launch of the institute’s five-year research strategy, which aims to broaden opportunities for high-quality translational research. A key component of the new strategy is the provision of research enablers, which will be instrumental in providing collaborative opportunities, modern platforms and infrastructure.
promoted as the vehicle for pursuing translational research priorities. “The Faculty of Medicine and Health and Northern Sydney Local Health District have now established the Northern Sydney Precinct unit, to provide dedicated local support for research performance, infrastructure and career development as well as grant management,” she said. “This will be a unique opportunity to explore new ways of pursuing our long-standing partnership, to deliver for our own communities, and to make our mark on the world stage.” NSLHD Chief Executive Deb Willcox said the research strategy will strengthen the Kolling’s reputation, both nationally and internationally, as a centre for translational research excellence. “With the Kolling located alongside Royal North Shore Hospital, researchers are embedded within a large health system,” she said. “This paves the way for strong collaborations between researchers and clinical teams, and efficiently delivers improvements to patient care and long term health outcomes.”
The research enablers will focus on the following areas: • Clinical trials and translation • Data and informatics • Research infrastructure and support services • Recruitment and retention Professor Elliott said the measures incorporated in the new strategy are aimed at assisting teams to increase the impact of their research. “They will provide a robust strategic framework, delivering new opportunities, access to high quality facilities and new partnerships both within and outside the organisation.” As a joint venture between the University of Sydney and the Northern Sydney Local Health District, the research strategy will see enhanced support from the joint venture partners. Professor Robyn Ward, Executive Dean and Pro Vice Chancellor of Medicine and Health at the University of Sydney said one of the key initiatives will see the Kolling
Three research priority areas were identified during the development of the strategy including musculoskeletal, neuroscience and pain, and cardiovascular and renal research. These areas represent some of the biggest health challenges of our time, and collectively cost the community billions of dollars a year with a health, personal, and economic burden. Acting Executive Director James Elliott said there is tremendous expertise across these disciplines within the Kolling, with many researchers world renowned in their fields. “Our research teams have a track record of success, a unique breadth of skills and knowledge and globally recognised expertise,” he said. “By focusing on these areas, we are moving to strengthen our ability to achieve game-changing research and ultimately improve the health of our local, national and international communities.”
8
KOLLINGNEWS | MAY 2021
Made with FlippingBook - professional solution for displaying marketing and sales documents online